Navidea Biopharmaceuticals IncのEPS Q / Q
Navidea Biopharmaceuticals IncのEPS Q / Qは何ですか。
Navidea Biopharmaceuticals IncのEPS Q / Qは-38.46%です。
EPS Q / Qの定義は何ですか。
四半期EPS成長率(Quarterly EPS growth rate)は、過去4四半期の業績と比較して過去4四半期のEPSの増加です。
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
NYSEMKTのセクタHealth CareにおけるEPS Q / Qの企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似のeps q / q
- Akzo Nobel NVのEPS Q / Qは-38.71%です。
- Aeglea BioTherapeutics IncのEPS Q / Qは-38.71%です。
- InflaRx N.VのEPS Q / Qは-38.71%です。
- GE AerospaceのEPS Q / Qは-38.60%です。
- Semler ScientificのEPS Q / Qは-38.55%です。
- First Foundation IncのEPS Q / Qは-38.55%です。
- Navidea Biopharmaceuticals IncのEPS Q / Qは-38.46%です。
- J&J Snack FoodsのEPS Q / Qは-38.41%です。
- Stemline TherapeuticsのEPS Q / Qは-38.36%です。
- Black Diamond Therapeutics IncのEPS Q / Qは-38.14%です。
- AngloGold Ashanti PlcのEPS Q / Qは-38.10%です。
- Franklin ResourcesのEPS Q / Qは-38.10%です。
- Allena Pharmaceuticals IncのEPS Q / Qは-38.10%です。